Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: A randomised controlled clinical trial

British Journal of Nutrition

Volumn 113, Issue 2, 2015, Pages 321-330

  Aliasgharzadeh, Akbar ^a   Dehghan, Parvin ^b   Gargari, Bahram Pourghassem ^c   Asghari Jafarabadi, Mohammad ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; Insulin resistance; Resistant dextrin; Type 2 diabetes

Indexed keywords

BUTYRIC ACID; C REACTIVE PROTEIN; DEXTRIN; ENDOTOXIN; FATTY ACID; GHRELIN; GLIBENCLAMIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; MALONALDEHYDE; MALTODEXTRIN; METFORMIN; PEPTIDE YY; PLACEBO; PREBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRIOSE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE DURATION; ENDOTOXEMIA; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PREMENOPAUSE; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; WEIGHT CHANGE; WEIGHT REDUCTION; BLOOD; COMPLICATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; FOLLOW UP; IMMUNOLOGY; IRAN; METABOLISM; MIDDLE AGED; OBESITY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BIOMARKERS; BODY MASS INDEX; CYTOKINES; DEXTRINS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTOXINS; ENERGY INTAKE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; IRAN; MALONDIALDEHYDE; MIDDLE AGED; OVERWEIGHT; PREBIOTICS;

EID: 84927516743     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514003675     Document Type: Article

References (47)

1. Lotfi MH, Saadati H & Afzali M (2014) Prevalence of diabetes in people aged $30 years: the results of screening program of Yazd province, Iran, in 2012. J Res Health Sci 14, 87-91.
2. Goldberg RB (2009) Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94, 3171-3182.
3. Zhang Y & Zhang H (2013) Microbiota associated with type 2 diabetes and its related complications. Food Sci Hum Wellness 2, 167-172.
4. Kaczmarczyk MM, Miller MJ & Freund GG (2012) The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism 61, 1058-1066.
5. Lefranc-Millot C (2008) NUTRIOSEw 06: a useful soluble dietary fibre for added nutritional value. Nutr Bull 33, 234-239.
6. Hobden MR, Martin-Morales A, Guérin-Deremaux L, et al. (2013) In vitro fermentation of NUTRIOSEw FB06, a wheat dextrin soluble fibre, in a continuous culture human colonic model system. PLOS ONE 8, e77128.
7. Pouillart PR, Depeint F, Abdelnour A, et al. (2010) Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets. Inflamm Bowel Dis 16, 783-794.
8. Knapp BK, Parsons CM, Bauer LL, et al. (2010) Soluble fiber dextrins and pullulans vary in extent of hydrolytic digestion in vitro and in energy value and attenuate glycemic and insulinemic responses in dogs. J Agric Food Chem 58, 11355-11363.
9. Li S, Guérin-Deremaux L, Pochat M, et al. (2010) NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study. Appl Physiol Nutr Metab 35, 773-782.
10. Guérin-Deremaux L, Pochat M, Reifer C, et al. (2013) Dose-response impact of a soluble fiber, NUTRIOSEw, on energy intake, body weight and body fat in humans. Global Epidemic Obesity 1, 1-8.
11. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27, Suppl. 1, S5-S10.
12. Saghaei M (2004) Random allocation software for parallel group randomized trials. BMC Med Res Methodol 4, 26.
13. Pocock SJ (1990) Clinical Trials-A Practical Approach, pp. 128. Chichester: John Wiley & Sons.
14. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
15. Katz A, Nambi SS, Mather K, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 2402-2410.
16. Del Rio D, Pellegrini N, Colombi B, et al. (2003) Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. Clin Chem 49, 690-692.
17. Pourghassem Gargari B, Dehghan P, Aliasgharzadeh A, et al. (2013) Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes Metab J 37, 140-148.
18. Dehghan P, Pourghassem Gargari B & Asghari Jafar-Abadi M (2014) Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial. Nutrition 30, 418-423.
19. Guérin-Deremaux L, Li S, Pochat M, et al. (2011) Effects of NUTRIOSEw dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men. Int J Food Sci Nutr 62, 628-635.
20. Amar J, Burcelin R, Ruidavets JB, et al. (2008) Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87, 1219-1223.
21. Bonsu Nana KA & Johnson Shanthi (2012) Effects of inulin fibre supplementation on serum glucose and lipid concentration in patients with type 2 diabetes. Int J Diabetes Metab 21, 80-86.
22. Cani PD, Lecourt E, Dewulf EM, et al. (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236-1243.
23. Lin HV, Frassetto A, Kowalik EJ Jr, et al. (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLOS ONE 7, e35240.
24. Kueht ML, McFarlin BK & Lee RE (2009) Severely obese have greater LPS-stimulated TNF-a production than normal weight African-American women. Obesity 17, 447-451.
25. Creely SJ, McTernan PG, Kusminski CM, et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740-E747.
26. Cani PD & Delzenne NM (2011) The gut microbiome as therapeutic target. Pharmacol Ther 130, 202-212.
27. Fujishiro M, Gotoh Y, Katagiri H, et al. (2003) Three mitogenactivated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol 17, 487-497.
28. Gao Z, Yin J, Zhang J, et al. (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517.
29. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
30. Shi X, Zhou F, Li X, et al. (2013) Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons. Cell Metab 18, 86-98.
31. Malaguarnera M, Vacante M, Antic T, et al. (2012) Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 57, 545-553.
32. Lecerf JM, Depeint F, Clerc E, et al. (2012) Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 108, 1847-1858.
33. Vulevic J, Juric A, Tzortzis G, et al. (2013) A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 143, 324-331.
34. Dehghan P, Gargari BP, Jafar-Abadi MA, et al. (2014) Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomizedcontrolled clinical trial. Int J Food Sci Nutr 65, 117-123.
35. Macfarlane S, Cleary S, Bahrami B, et al. (2013) Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebocontrolled crossover study. Aliment Pharmacol Ther 38, 804-816.
36. Anderson AD, McNaught CE, Jain PK, et al. (2004) Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53, 241-245.
37. van den Heuvel EG, Wils D, Pasman WJ, et al. (2005) Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men. Eur J Nutr 44, 445-451.
38. Suzuki A, Mitsuyama K, Koga H, et al. (2006) Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition 22, 76-81.
39. Lefranc-Millot C, Wils D, Neut C, et al. (2006) Effects of a soluble fibre with excellent tolerance, NUTRIOSEw 06, on the gut ecosystem: a review. In Proceedings of The Dietary Fibre Conference 2006, p. 34, Helsinki, Finland.
40. Mohamadzadeh M, Pfeiler EA, Brown JB, et al. (2011) Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 108, 4623-4630.
41. Lefranc-Millot C, Wils D, Henry J, et al. (2006) NUTRIOSEw, a resistant dextrin, and MALTISORBw, a sugar alcohol, two key ingredients for healthy diets and obesity management. Obes Rev 7, S269.
42. Place RF, Noonan EJ & Giardina C (2005) HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes IκBa. Biochem Pharmacol 70, 394-406.
43. Weber TE & Kerr BJ (2006) Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol 113, 139-147.
44. Schwab M, Reynders V, Loitsch S, et al. (2007) Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF-κB signaling. Mol Immunol 44, 3625-3632.
45. Zenhom M, Hyder A, de Vrese M, et al. (2011) Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARg and peptidoglycan recognition protein 3. J Nutr 141, 971-977.
46. Rishi P, Mavi SK, Bharrhan S, et al. (2009) Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiol Ecol 69, 222-230.
47. King GL & Loeken MR (2004) Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122, 333-338.